Bridging the B Cell Gap: Novel Technologies to Study Antigen-Specific Human B Cell Responses
Henry A Utset1, Jenna J Guthmiller1, Patrick C Wilson1,2
1Department of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637, USA.
Vaccines
|August 6, 2021
Summary
New technologies link B cell function to antibody repertoire and antigen specificity, improving vaccine design. This research aids in developing vaccines against pathogens like influenza and SARS-CoV-2.
Area of Science:
- Immunology
- Vaccinology
Background:
- High-affinity antibody generation is key to immunity from vaccines and infections.
- Understanding B cell responses is vital for effective vaccines against pathogens like influenza, HIV, and SARS-CoV-2.
- Current humoral immunity studies are limited by serological focus, restricting knowledge of B cell specificity and function.
Purpose of the Study:
- To review recent innovations connecting B cell function with repertoire and antigen specificity.
- To highlight advances in ex vivo and in vivo models for studying human B cell responses.
- To demonstrate how these technologies can aid in designing and validating new vaccine platforms.
Main Methods:
- Review of recent technological innovations in B cell research.
- Analysis of advancements in ex vivo and in vivo modeling of human B cell responses.
Main Results:
- New technologies enable a stronger connection between B cell function, repertoire, and antigen specificity.
- Significant progress has been made in developing models to study human B cell immunity.
- These advancements offer tools for improved vaccine design and validation.
Conclusions:
- Technological innovations are enhancing our understanding of B cell responses.
- Improved models facilitate the study of human B cell immunity.
- The reviewed technologies are crucial for developing next-generation vaccines.
Keywords:
B cell repertoiresRNA-sequencingbone marrowbroadly neutralizing antibodiesfine needle aspiratesgerminal centerhuman B cellshumanized micehumoral immunitylymph nodeMore Related Videos
Related Concept Videos
Hybridoma Technology
16.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
16.1K
B Cell Activation and Differentiation
12.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
12.6K
Diversity of Antigen Receptors
998
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
998


